According to data collected by the World Health Organization (WHO) in 3,000 cities worldwide, 92% of the world's population lives in places where the level of air quality exceeds the limits set by international environmental agreements for total emissions of atmospheric pollutants.

Exposure to electrosmog, various chemicals such as herbicides and insecticides, formaldehyde, PFAS, and the production of polluting gases, as well as a stressful lifestyle, have created a toxic environment for human health.

This scenario has contributed to the emergence and spread of so-called environmental diseases, including many dermatological, tumor, and rare diseases.

Some of these, such as multiple chemical sensitivity (MCS), struggle to be recognized by the scientific community. Others, such as chronic fatigue syndrome (ME/CFS), although already on the World Health Organization's list, are not recognized in several European states, including Italy. Fibromyalgia, although it has a treatment protocol, is very difficult for the medical community to diagnose.

​

As an MCS patient, I experienced this isolation for several years, putting a strong strain on my physical and mental health and my relationships. During this period of isolation, I often questioned whether technological, industrial, and economic progress that permeates all our lives should change direction and begin investing in innovative research to benefit people and the environment.

This requires a radical paradigm shift and a collective effort involving institutions, healthcare providers, businesses, and citizens.